DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 127 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,159,168 | +7.0% | 575,800 | +34.4% | 0.02% | +7.1% |
| Q2 2023 | $4,820,951 | -54.6% | 428,529 | -53.5% | 0.01% | -57.6% |
| Q1 2023 | $10,611,473 | -34.0% | 921,135 | -33.6% | 0.03% | -40.0% |
| Q4 2022 | $16,083,072 | -15.4% | 1,387,668 | -7.3% | 0.06% | -27.6% |
| Q3 2022 | $19,020,000 | +102.6% | 1,497,631 | +9.6% | 0.08% | +90.0% |
| Q2 2022 | $9,387,000 | -48.4% | 1,366,400 | -27.6% | 0.04% | -44.4% |
| Q1 2022 | $18,199,000 | +22.0% | 1,887,900 | +50.5% | 0.07% | +20.0% |
| Q4 2021 | $14,920,000 | +11.1% | 1,254,800 | +51.7% | 0.06% | +1.7% |
| Q3 2021 | $13,430,000 | -6.3% | 827,000 | +21.5% | 0.06% | -7.8% |
| Q2 2021 | $14,326,000 | +161.2% | 680,900 | +92.8% | 0.06% | +146.2% |
| Q1 2021 | $5,484,000 | +1257.4% | 353,115 | +1665.6% | 0.03% | +1200.0% |
| Q3 2020 | $404,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |